IDO is thought to suppress GVHD lethality, potentially by suppressing TH1 differentiation in favor of CD4+FoxP3+ TREG stimulation (100, 101) which could also lead to a more tolerogenic state against apoptotic cells resulting from conditioning-related damage (102–104). The gene discussed is FOXP3; the disease is graft versus host disease.